The "JAK3 Gene SCID Autosomal Recessive T Negative B Positive Type Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the JAK3 gene that are associated with a specific form of severe combined immunodeficiency (SCID). This rare genetic disorder is characterized by the autosomal recessive inheritance of a condition where individuals have an absence of T lymphocytes but normal levels of B lymphocytes (T- B+ SCID). This specific phenotype is crucial for directing appropriate treatment and management strategies for affected individuals.
The JAK3 gene plays a pivotal role in the immune system, particularly in the development and function of T cells. Mutations in this gene disrupt these processes, leading to a compromised immune system that is highly susceptible to infections. Early detection through this genetic test is vital for the timely intervention that can significantly improve the quality of life and survival rates of affected individuals.
The test is conducted at DNA Labs UAE, a facility known for its advanced genetic testing services. The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the comprehensive insights it provides into the genetic underpinnings of this form of SCID. This genetic test is a crucial tool for families with a history of SCID, providing them with the necessary information for family planning and the management of the condition in affected family members.
The APOE Gene Sea-Blue Histiocyte Disease Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at identifying mutations in the APOE gene, which are associated with Sea-Blue Histiocyte Disease. This rare genetic disorder is characterized by the accumulation of sea-blue histiocytes within the bone marrow, spleen, and liver, leading to a variety of symptoms including hepatosplenomegaly, thrombocytopenia, and neurocognitive issues. The APOE gene plays a crucial role in lipid metabolism, and mutations in this gene can disrupt this process, contributing to the development of the disease.
The test is conducted using a blood sample, where DNA is extracted and analyzed for specific mutations in the APOE gene. This genetic testing is vital for accurate diagnosis, allowing for personalized treatment plans and management strategies to be developed for affected individuals. It also provides essential information for family planning and genetic counseling for families with a history of the disease.
The cost of the APOE Gene Sea-Blue Histiocyte Disease Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to detect the presence of APOE gene mutations, providing patients and their families with crucial information regarding the condition. Given the complexity of genetic testing and the specialized expertise required, the cost reflects the value of obtaining a precise diagnosis and the potential to significantly impact the patient's quality of life and healthcare management.
The SBDS Gene Shwachman-Diamond Syndrome Genetic Test is a specialized diagnostic procedure designed to identify mutations in the SBDS gene, which are associated with Shwachman-Diamond Syndrome (SDS). SDS is a rare congenital disorder characterized by bone marrow dysfunction, skeletal abnormalities, and pancreatic insufficiency. This genetic test is crucial for the accurate diagnosis of SDS, enabling appropriate management and treatment plans for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw. The sample is then analyzed using advanced genetic sequencing technologies to detect any mutations in the SBDS gene that are indicative of Shwachman-Diamond Syndrome.
The cost of the SBDS Gene Shwachman-Diamond Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price may cover the genetic testing procedure, analysis, and a comprehensive report detailing the findings. It's essential for patients or their guardians to consult with healthcare providers to understand the implications of the test results fully and discuss the next steps in care or treatment if a mutation is detected.
The HBB Gene Sickle Cell Anemia Genetic Test is a specialized medical examination conducted to detect mutations in the HBB gene, which are responsible for sickle cell anemia. Sickle cell anemia is a severe hereditary form of anemia in which a mutated form of hemoglobin distorts the red blood cells into a sickle shape at low oxygen levels. These irregularly shaped cells can then obstruct blood flow, causing pain, infections, and other serious health problems.
The test is particularly important for individuals with a family history of sickle cell anemia or those belonging to ethnic groups that are at a higher risk of the disease. By analyzing a sample of the patient's DNA, the test can confirm the presence of the specific mutations in the HBB gene that cause the disorder, thereby facilitating early diagnosis and management of the condition.
This genetic test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the HBB Gene Sickle Cell Anemia Genetic Test at DNA Labs UAE is 4400 AED. This investment can provide crucial information for the proactive management of sickle cell anemia, including guidance on treatment options and strategies to prevent complications associated with the disease.
The TRNT1 Gene Sideroblastic Anemia with B-Cell Immunodeficiency, Periodic Fevers, and Developmental Delay Genetic Test is a specialized diagnostic tool available at DNA Labs UAE. This test is specifically designed to detect mutations in the TRNT1 gene, which have been associated with a rare, complex condition characterized by sideroblastic anemia, B-cell immunodeficiency, periodic fevers, and developmental delays. The condition represents a spectrum of clinical manifestations resulting from impaired function of the TRNT1 gene, crucial for RNA processing and mitochondrial function.
The test involves collecting a DNA sample, usually through a blood draw, and analyzing the genetic material for specific mutations in the TRNT1 gene. Early diagnosis through this genetic test can significantly impact the management and treatment strategies for affected individuals, offering insights into potential interventions and the course of the disease.
At DNA Labs UAE, this comprehensive genetic test is offered at a cost of 4400 AED. Given the specialized nature of the test and its potential to provide critical information for managing a complex array of symptoms, it represents a valuable investment for affected individuals and their families seeking clarity on diagnosis and guidance on potential therapeutic approaches.
The ANK1 Gene Spherocytosis Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the ANK1 gene that are associated with Hereditary Spherocytosis Type 1. Hereditary Spherocytosis is a condition characterized by anemia, jaundice, and an enlarged spleen due to the presence of spherical red blood cells, which are more prone to breaking apart. The test is crucial for individuals showing symptoms of the condition or those with a family history, as it aids in confirming the diagnosis, understanding the severity, and planning appropriate treatment strategies.
This test specifically targets the ANK1 gene, mutations in which are known to cause a significant proportion of Hereditary Spherocytosis cases. The procedure involves collecting a DNA sample, usually through a blood draw, which is then analyzed in the laboratory to detect any genetic abnormalities present within the ANK1 gene.
The cost of the ANK1 Gene Spherocytosis Type 1 Genetic Test at DNA Labs UAE is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify mutations within the gene. For patients and families affected by Hereditary Spherocytosis, this test provides essential information that can guide treatment decisions and offer insights into the genetic underpinnings of their condition.
The "SPTB Gene Spherocytosis Type 2 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the SPTB gene, which are linked to Hereditary Spherocytosis Type 2. This condition is a form of hereditary anemia characterized by the production of abnormally shaped red blood cells that are prone to destruction, leading to symptoms such as jaundice, anemia, splenomegaly, and gallstones. The test is crucial for the accurate diagnosis and management of the condition, enabling targeted treatment strategies and genetic counseling for affected individuals and their families.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test offers a reliable solution for those suspecting or at risk of having Hereditary Spherocytosis Type 2. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the sophisticated technology employed to detect the specific gene mutations. By opting for this test, patients and healthcare providers can gain valuable insights into the genetic underpinnings of the condition, facilitating informed decisions regarding healthcare and management of the disorder.
The SPTA1 gene spherocytosis type 3 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the SPTA1 gene, which are associated with Hereditary Spherocytosis type 3. This condition is a form of hereditary spherocytosis, a disorder characterized by anemia, jaundice, and an enlarged spleen, due to the production of abnormally shaped red blood cells. The test plays a crucial role in confirming the diagnosis, enabling targeted treatment and management strategies for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test offers a comprehensive analysis of the SPTA1 gene to detect any genetic anomalies that may lead to the condition. The cost of the test is 4400 AED, reflecting the intricate technology and expertise required to accurately identify mutations in the gene. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for personalized medical care and informed decision-making regarding their health.
The EPB42 gene plays a crucial role in the stability and shape of red blood cells. Mutations in this gene are associated with hereditary spherocytosis type 5, a genetic condition characterized by anemia, jaundice, and an enlarged spleen due to the abnormal shape of red blood cells. To diagnose this condition, a genetic test targeting the EPB42 gene can be conducted.
DNA Labs UAE offers this specific genetic test to identify mutations in the EPB42 gene, providing crucial information for the diagnosis and management of hereditary spherocytosis type 5. The test is priced at 4400 AED and is conducted in their state-of-the-art facilities, ensuring accurate and reliable results. This genetic test is a vital tool for affected individuals and their families to understand their condition better and make informed health decisions.
The STIM1 Gene Stormorken Syndrome Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the STIM1 gene, which are associated with Stormorken syndrome. This rare, autosomal dominant condition is characterized by a constellation of symptoms including thrombocytopenia, asplenia, miosis, ichthyosis, short stature, and muscle weakness. The test involves analyzing the patient's DNA to pinpoint any genetic anomalies in the STIM1 gene that may lead to the syndrome, providing crucial information for accurate diagnosis and management.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test offers individuals and families a chance to understand their genetic makeup regarding this rare condition. The cost of the STIM1 Gene Stormorken Syndrome Genetic Test is 4400 AED. This investment covers the comprehensive analysis and detailed reporting necessary to guide patients and healthcare providers towards appropriate treatment plans and potential preventive measures for affected family members.
